Prognostic Landscape of TP53 Mutations in Hematologic Malignancies

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• TP53 mutations are linked to poor prognosis in blood cancers.
• The functional consequences of these mutations are not fully understood.
• This study investigates TP53 mutation impact across hematologic malignancies.

Purpose of the Study:

• To analyze the spectrum of TP53 mutations in hematologic malignancies.
• To evaluate the functional impact of TP53 mutations using scoring methods.
• To assess the relationship between mutation characteristics and overall survival.

Main Methods:

• Targeted sequencing of TP53 in 856 patients with hematologic malignancies.
• Application of Evolutionary Action (EAp53) and Relative Fitness Score (RFS) for functional impact assessment.
• Statistical analysis of Variant Allele Frequency (VAF), mutation type, EAp53, RFS, and Overall Survival (OS).

Main Results:

• TP53 mutations were associated with inferior OS (median 10.0 months) compared to wildtype.
• High VAF (>50%) and high RFS (>0.22) significantly correlated with poorer OS.
• No significant survival difference was found for EAp53 scores or mutation disruptiveness.

Conclusions:

• VAF and RFS are valuable prognostic tools for TP53-mutant hematologic malignancies.
• These metrics aid in stratifying patients into high- and low-risk groups.
• Further research can refine risk stratification and treatment strategies.